Oncolytic H-1 Parvovirus Shows Safety and Signs of Immunogenic Activity in a First Phase I/IIa Glioblastoma TrialMOLECULAR THERAPYIF122017-12-01201OAAI
Double-faceted mechanism of parvoviral oncosuppressionCURRENT OPINION IN VIROLOGYIF5.12015-08-0127PREAI
Sorafenib Sensitizes Glioma Cells to the BH3 Mimetic ABT-737 by Targeting MCL1 in a STAT3-Dependent MannerNEOPLASIAIF7.72015-07-0139OAAI
Regression of Glioma in Rat Models by Intranasal Application of Parvovirus H-1CLINICAL CANCER RESEARCHIF10.22011-08-1432PREAI
Regression of advanced rat and human gliomas by local or systemic treatment with oncolytic parvovirus H-1 in rat modelsNEURO-ONCOLOGYIF13.42010-03-1892OAAI
Oncolytic Rat Parvovirus H-1PV, a Candidate for the Treatment of Human Lymphoma: In Vitro and In Vivo StudiesMOLECULAR THERAPYIF122009-07-0151OAAI
Reoxygenation increases the release of reactive oxygen intermediates in murine microgliaJOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISMIF4.51998-06-0132OAAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向